Blog | Laxxon Medical

3 days ago2 min

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical , a US-based pharma-technology company pioneering a new generation of...

Oct 23 min

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP fa

May 222 min

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

Learn more about Laxxon Medical's groundbreaking 3D printed oral GLP-1 asset, offering an alternative to injections in obesity treatments.

May 206 min

Investing in Safety: Laxxon Medical's QR Code Technology and the Fight Against Counterfeit Drugs

Counterfeit medicine is a threat to public health. Technologies like 3D printing and QR codes help protect both patients and drug integrity.

May 162 min

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024

Laxxon Medical announced its participation in the 2024 BIO International Convention, to showcase its LXM.2 asset to potential partners.

May 133 min

LXM.2 A 3D printed oral GLP-1 Agonist for weight loss

LXM.2 is Laxxon Medical’s oral GLP-1 Agonist treatment for weight loss, offering patients a non-invasive, once-a-day treatment made...

May 65 min

Understanding GLP-1 Medications for Diabetes and Obesity

Learn all about GLP-1 medications for diabetes and obesity, including benefits, side effects, and how they work.

Apr 293 min

The Controlled Release Drug Delivery Market

Explore the future of drug delivery, Laxxon Medical's innovative 3D technology, and how controlled-release drugs are reshaping healthcare.

Apr 232 min

Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024

Join Dr.Catherine Gatza, our VP of Regulatory Affairs, at the World Orphan Drug Congress USA 2024, in Boston, Massachusetts.

Apr 226 min

Revolutionizing Parkinson's Treatment: How Laxxon's Extended-Release Levodopa Improves Quality of Life

Laxxon's extended-release Levodopa is revolutionizing Parkinson's treatment, increasing patient quality of life with improved medication.